Australia markets open in 5 hours 38 minutes

Lantern Pharma Inc. (LTRN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.27+0.08 (+1.29%)
As of 02:16PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2233
Avg. Estimate-0.55-0.59-2.22-1.9
Low estimate-0.56-0.62-2.36-2.02
High estimate-0.55-0.57-2.06-1.82
Year ago EPS-0.44-0.29-1.47-2.22
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2233
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.43-0.45-0.4-0.43
Actual EPS-0.44-0.29-0.39-0.51
Difference-0.010.160.01-0.08
Surprise %-2.30%35.60%2.50%-18.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.55-0.59-2.22-1.9
7 days ago-0.48-0.54-2.03-1.88
30 days ago-0.48-0.54-2.02-1.91
60 days ago00-1.96-1.43
90 days ago00-1.96-1.43
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1121
Growth estimatesLTRNIndustrySector(s)S&P 500
Current qtr.-25.00%N/AN/AN/A
Next qtr.-103.40%N/AN/AN/A
Current year-51.00%N/AN/AN/A
Next year14.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A